vs
Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $32.6M, roughly 1.1× RxSight, Inc.). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -28.1%, a 33.2% gap on every dollar of revenue. On growth, NATIONAL RESEARCH CORP posted the faster year-over-year revenue change (-4.6% vs -18.9%). NATIONAL RESEARCH CORP produced more free cash flow last quarter ($6.1M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
NRC vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $32.6M |
| Net Profit | $1.8M | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | 13.3% | -34.8% |
| Net Margin | 5.1% | -28.1% |
| Revenue YoY | -4.6% | -18.9% |
| Net Profit YoY | -72.6% | -54.1% |
| EPS (diluted) | $49.58 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $32.6M | ||
| Q3 25 | $34.6M | $30.3M | ||
| Q2 25 | $34.0M | $33.6M | ||
| Q1 25 | $33.6M | $37.9M | ||
| Q4 24 | $36.9M | $40.2M | ||
| Q3 24 | $35.8M | $35.3M | ||
| Q2 24 | $35.0M | $34.9M | ||
| Q1 24 | $35.3M | $29.5M |
| Q4 25 | $1.8M | $-9.2M | ||
| Q3 25 | $4.1M | $-9.8M | ||
| Q2 25 | $-106.0K | $-11.8M | ||
| Q1 25 | $5.8M | $-8.2M | ||
| Q4 24 | $6.6M | $-5.9M | ||
| Q3 24 | $5.7M | $-6.3M | ||
| Q2 24 | $6.2M | $-6.1M | ||
| Q1 24 | $6.4M | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | 13.3% | -34.8% | ||
| Q3 25 | 22.4% | -40.1% | ||
| Q2 25 | 4.7% | -41.6% | ||
| Q1 25 | 25.6% | -28.2% | ||
| Q4 24 | 26.0% | -21.5% | ||
| Q3 24 | 22.3% | -26.1% | ||
| Q2 24 | 25.3% | -23.9% | ||
| Q1 24 | 24.8% | -36.2% |
| Q4 25 | 5.1% | -28.1% | ||
| Q3 25 | 11.9% | -32.4% | ||
| Q2 25 | -0.3% | -35.0% | ||
| Q1 25 | 17.2% | -21.6% | ||
| Q4 24 | 17.8% | -14.8% | ||
| Q3 24 | 15.9% | -17.9% | ||
| Q2 24 | 17.6% | -17.4% | ||
| Q1 24 | 18.0% | -30.8% |
| Q4 25 | $49.58 | $-0.22 | ||
| Q3 25 | $0.18 | $-0.24 | ||
| Q2 25 | $-0.01 | $-0.29 | ||
| Q1 25 | $0.25 | $-0.20 | ||
| Q4 24 | $0.27 | $-0.14 | ||
| Q3 24 | $0.24 | $-0.16 | ||
| Q2 24 | $0.26 | $-0.16 | ||
| Q1 24 | $0.27 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $275.7M |
| Total Assets | $134.9M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $228.1M | ||
| Q3 25 | $2.2M | $227.5M | ||
| Q2 25 | $5.3M | $227.5M | ||
| Q1 25 | $2.5M | $229.3M | ||
| Q4 24 | $4.2M | $237.2M | ||
| Q3 24 | $3.5M | $237.1M | ||
| Q2 24 | $485.0K | $233.3M | ||
| Q1 24 | $1.7M | $125.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $48.7M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $35.2M | — |
| Q4 25 | $14.0M | $275.7M | ||
| Q3 25 | $14.3M | $276.0M | ||
| Q2 25 | $21.3M | $278.0M | ||
| Q1 25 | $29.7M | $279.3M | ||
| Q4 24 | $31.3M | $281.2M | ||
| Q3 24 | $34.6M | $277.3M | ||
| Q2 24 | $40.2M | $275.2M | ||
| Q1 24 | $36.9M | $163.9M |
| Q4 25 | $134.9M | $311.8M | ||
| Q3 25 | $135.7M | $308.5M | ||
| Q2 25 | $141.4M | $309.0M | ||
| Q1 25 | $135.2M | $313.0M | ||
| Q4 24 | $132.5M | $318.6M | ||
| Q3 24 | $131.8M | $310.5M | ||
| Q2 24 | $119.1M | $305.5M | ||
| Q1 24 | $120.9M | $183.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.2M | $-1.1M |
| Free Cash FlowOCF − Capex | $6.1M | $-2.3M |
| FCF MarginFCF / Revenue | 17.2% | -6.9% |
| Capex IntensityCapex / Revenue | 3.2% | 3.5% |
| Cash ConversionOCF / Net Profit | 3.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | $15.7M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.2M | $-1.1M | ||
| Q3 25 | $13.8M | $-1.2M | ||
| Q2 25 | $-1.1M | $-4.4M | ||
| Q1 25 | $6.6M | $-8.8M | ||
| Q4 24 | $6.4M | $-4.3M | ||
| Q3 24 | $9.4M | $650.0K | ||
| Q2 24 | $6.8M | $-4.0M | ||
| Q1 24 | $12.0M | $-9.3M |
| Q4 25 | $6.1M | $-2.3M | ||
| Q3 25 | $10.2M | $-1.8M | ||
| Q2 25 | $-4.1M | $-5.9M | ||
| Q1 25 | $3.7M | $-9.4M | ||
| Q4 24 | $1.9M | $-5.1M | ||
| Q3 24 | $7.8M | $-453.0K | ||
| Q2 24 | $1.5M | $-5.5M | ||
| Q1 24 | $7.9M | $-11.3M |
| Q4 25 | 17.2% | -6.9% | ||
| Q3 25 | 29.4% | -5.8% | ||
| Q2 25 | -12.2% | -17.6% | ||
| Q1 25 | 10.9% | -24.8% | ||
| Q4 24 | 5.2% | -12.7% | ||
| Q3 24 | 21.8% | -1.3% | ||
| Q2 24 | 4.3% | -15.9% | ||
| Q1 24 | 22.4% | -38.2% |
| Q4 25 | 3.2% | 3.5% | ||
| Q3 25 | 10.4% | 1.9% | ||
| Q2 25 | 8.8% | 4.6% | ||
| Q1 25 | 8.9% | 1.5% | ||
| Q4 24 | 12.0% | 2.1% | ||
| Q3 24 | 4.5% | 3.1% | ||
| Q2 24 | 15.0% | 4.4% | ||
| Q1 24 | 11.7% | 6.7% |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 1.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NRC
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
